132 related articles for article (PubMed ID: 15890239)
1. Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide.
Khalikova TA; Zhanaeva SY; Korolenko TA; Kaledin VI; Kogan G
Cancer Lett; 2005 Jun; 223(1):77-83. PubMed ID: 15890239
[TBL] [Abstract][Full Text] [Related]
2. Mouse lymphosarcomas sensitive and resistant to cyclophosphamide therapy: activity of cathepsins B, L, and D during various schemes of treatment with cyclophosphamide and SE-glycan.
Usova TA; Zhanaeva SY; Kogan G; Shandula I; Korolenko TA
Bull Exp Biol Med; 2003 Nov; 136(5):451-4. PubMed ID: 14968157
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
4. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
5. [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
Khalikova TA; Korolenko TA; Il'nitskaia SI
Biomed Khim; 2009; 55(5):621-34. PubMed ID: 20017393
[TBL] [Abstract][Full Text] [Related]
6. Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosarcoma.
Poteryaeva ON; Falameeva OV; Zhanaeva SY; Svechnikova IG; Korolenko TA; Kaledin VI
Bull Exp Biol Med; 2001 Jul; 132(1):675-7. PubMed ID: 11687851
[TBL] [Abstract][Full Text] [Related]
7. Effect of cysteine protease inhibitor Ep-475 on TNF-alpha-independent cyclophosphamide-induced apoptosis in mouse lymphosarcoma LS cells.
Zhanaeva SY; Korolenko TA; Khoshchenko OM; Spiridonov VK; Nikolin VP; Kaledin VI
Bull Exp Biol Med; 2005 Feb; 139(2):186-9. PubMed ID: 16027802
[TBL] [Abstract][Full Text] [Related]
8. Activity of cathepsins and morphological changes in the rat's liver after ranitidine and famotidine administration.
Burdan F; Burak B; Burski K; Ruciński P; Pliszczyńska M
Ann Univ Mariae Curie Sklodowska Med; 1999; 54():299-302. PubMed ID: 11205779
[No Abstract] [Full Text] [Related]
9. Activation of cathepsins B and L in mouse lymphosarcoma tissue under the effect of cyclophosphamide is associated with apoptosis induction and infiltration by mononuclear phagocytes.
Zhanaeva SY; Mel'nikova EV; Trufakin VA; Korolenko TA
Bull Exp Biol Med; 2013 Nov; 156(1):86-90. PubMed ID: 24319737
[TBL] [Abstract][Full Text] [Related]
10. Use of 2-methylpropan-2-ol to inhibit proteolysis and other protein interactions in a tissue homogenate: an illustrative application to the extraction of cathepsins B and L from liver tissue.
Dennison C; Moolman L; Pillay CS; Meinesz RE
Anal Biochem; 2000 Aug; 284(1):157-9. PubMed ID: 10933869
[No Abstract] [Full Text] [Related]
11. [Expression of cathepsins D and L during neoplastic transformation of fibroblasts].
Dilakian EA; Balaevskaia TO; Zakamaldina-Tsama TA; Topol' LZ; Solov'eva NI
Vopr Med Khim; 1994; 40(3):2-6. PubMed ID: 8079433
[TBL] [Abstract][Full Text] [Related]
12. Release of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulation.
Mayer K; Vreemann A; Qu H; Brix K
Biol Chem; 2009; 390(5-6):471-80. PubMed ID: 19284293
[TBL] [Abstract][Full Text] [Related]
13. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.
Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW
Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of lysosomal cysteine proteases in the estimation of the effectiveness of the antitumorigenic therapy].
Zhanaeva SIa; D'iakov AI; Alekseenko TA; Korolenko TA
Biomed Khim; 2009; 55(1):89-97. PubMed ID: 19351038
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
16. Laminar shear stress inhibits cathepsin L activity in endothelial cells.
Platt MO; Ankeny RF; Jo H
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1784-90. PubMed ID: 16709945
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin activities and membrane integrity of zebrafish (Danio rerio) oocytes after freezing to -196 degrees C using controlled slow cooling.
Zhang T; Rawson DM; Tosti L; Carnevali O
Cryobiology; 2008 Apr; 56(2):138-43. PubMed ID: 18289520
[TBL] [Abstract][Full Text] [Related]
18. Thyroid functions of mouse cathepsins B, K, and L.
Friedrichs B; Tepel C; Reinheckel T; Deussing J; von Figura K; Herzog V; Peters C; Saftig P; Brix K
J Clin Invest; 2003 Jun; 111(11):1733-45. PubMed ID: 12782676
[TBL] [Abstract][Full Text] [Related]
19. Neuronal loss and brain atrophy in mice lacking cathepsins B and L.
Felbor U; Kessler B; Mothes W; Goebel HH; Ploegh HL; Bronson RT; Olsen BR
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7883-8. PubMed ID: 12048238
[TBL] [Abstract][Full Text] [Related]
20. Expression and induction of cathepsins B and D in K562 cells.
Murnane MJ; Phipps PM; Denekamp DS
Exp Hematol; 1988 Jan; 16(1):33-7. PubMed ID: 3335232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
